For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230111:nRSK3095Ma&default-theme=true
RNS Number : 3095M IP Group PLC 11 January 2023
FOR RELEASE ON 11 January 2023
IP Group plc - Portfolio company Oxbotica raises $140m Series C investment
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which develops
world-changing science and technology businesses, is delighted to announce
that portfolio company Oxbotica Ltd ("Oxbotica" or "the Company"), the global
leader in autonomous vehicle software, has raised $140m (£115m*) in a Series
C investment round.
Kiko Ventures, IP Group's cleantech platform, supported the round
which included financial and strategic partners from North America, EMEA and
APAC, including new investors including Aioi Nissay Dowa Insurance Co., Ltd
and ENEOS Innovation Partners and current shareholders bp ventures, BGF,
Halma, Hostplus, Ocado Group, Tencent, Venture Science and ZF, amongst other
global companies. Following today's announcement, Oxbotica has raised
approximately US$225m to date.
The funding will drive Oxbotica's geographical expansion in North America,
EMEA and APAC, and accelerate the deployment of its ground-breaking autonomy
operating system in domains where there is both urgent need and potential to
scale, such as agriculture, airports, energy, goods delivery, mining and
shared passenger transportation.
As previously announced on 02 December 2022, IP Group recorded a net
unrealised fair value gain of approximately £36m or approximately 4p per
share following the first close of the round. IP Group committed £4.2m to the
funding round. Parkwalk, IP Group's wholly owned EIS fund manager, has also
invested £9.9m in Oxbotica to date.
Jamie Vollbracht, Founding Partner at Kiko Ventures, said: "Crucially,
Oxbotica is deploying solutions in applications where there is a need for
autonomy today. The systemic benefits of such autonomy solutions, and how they
will radically improve the future of transportation, shouldn't be
underestimated! We are delighted to be part of the journey with the team and
congratulate the leadership on this substantial fundraise."
Moray Wright, CEO at Parkwalk Advisors, said: "We are absolutely delighted to
see Oxbotica raise the funding required to fulfil their commercial
opportunities. The team's unique technology and architecture has multiple
applications which is why Parkwalk joined forces with IP Group's cleantech
team to lead the Seed and Series A funding rounds in 2018 and 2019
respectively."
Oxbotica is a global leader in autonomous vehicle software for businesses and
aims to unlock the benefits of self-driving technology to every person and
every organisation on the planet. Oxbotica's suite of products (Oxbotica
Driver™, Oxbotica Cloud™, and Oxbotica MetaDriver™) is enabling
Universal Autonomy™: the ability of any vehicle, of any size, in any
location to operate autonomously, safely, and sustainably.
*GBP equivalent using 1.21 USD/GBP
For more information, please contact:
IP Group plc www.ipgroupplc.com (http://www.ipgroupplc.com)
Liz Vaughan-Adams, Communications +44 (0) 20 7444 0062/+44 (0) 7967 312125
Portland
Vic Wallin +44 (0) 7973 823 119
Alex Donaldson +44 (0) 7516 729 702
Notes for editors
About IP Group
IP Group develops world-changing science and technology businesses across
life sciences, technology and cleantech (through Kiko Ventures). The Group has
a strong track record of success, having been the founder investor in a number
of high-profile companies including Oxford Nanopore Technologies plc, and has
one of the most exciting portfolios of high-growth businesses in Europe. The
Group also owns Parkwalk, the UK's largest growth EIS fund manager which backs
world-changing technologies emerging from the UK's leading universities and
research institutions. IP Group is listed on the Main Market of the London
Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com
(http://www.ipgroupplc.com/) .
ENDS
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCURAKROAUAAAR